Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Daschle, Peanut Butter Put FDA Commissioner Choice In Sticky Situation

This article was originally published in The Gray Sheet

Executive Summary

The withdrawal of Tom Daschle's nomination as HHS secretary may delay the announcement of an FDA commissioner, but does not change the two names on the Obama administration's shortlist

You may also be interested in...

GAO “High-Risk List” Urges Enhanced FDA Oversight Of Medical Products

The Government Accountability Office added enhanced oversight of devices, drugs and other medical products to its list of "high-risk" priorities in a report to Congress released Jan. 22

Race For FDA Commissioner Almost Over: Will It End With Sharfstein Or Califf?

The Obama transition team has concluded its search for a new FDA commissioner, stakeholders said late last week

HHS Deputy Corr Could Reignite Debate Over FDA Tobacco Oversight

HHS Secretary-designate Tom Daschle's pick of William Corr as deputy secretary will be a key policy appointment should the Obama administration decide to make FDA regulation of tobacco a priority

Related Content





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts